Ezra Klein 2023-11-22. Dangers of no regulation or excess
by Larry Levitt, EVP of Kaiser Family Foundation
key materials, locations
2021-Dec-10. Leonhardt on innovation returns to govt investments in research
capital gains rather than royalties as one factor
Amy Finkelstein on Medicare rule impact on Rx prices vs private insurance bargaining power
dominant firm in China needs apps, but may hurt innovation
various mining proposals in US - for electric car batteries etc
looking ahead. patents and lack of intl aid issues
maybe introduce early in IO course for discussion
book Bottle of Lies by Katherine Eban - review by David Dobbs. review in print 2019-06-30
2019--01-11
Porter: Supreme Court case challenging Patent Trial and Appeal Board
Mullainathan: with less public funding, high drug Ps may be needed incentive for private R&D.
Morgenson on Lannett Company - also facing antitrust and price-fixing inquiries
Lexmark International
Amazon history of taking risks with new products and services
innovation and low production costs help growth in production